World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
35061
World Ranking
8922
National Ranking
4591

Overview

Jordan U. Gutterman is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily intersects the fields of biochemistry, genetics, molecular biology, immunology, and microbiology, with particular contributions within several subfields such as molecular biology, immunology, cell biology, genetics, and biomedical engineering.

The scientist's work spans a range of important topics in biomedical research. These topics include:

  • Toxin Mechanisms and Immunotoxins
  • Sphingolipid Metabolism and Signaling
  • Cellular Transport and Secretion
  • Evolution and Genetic Dynamics
  • Slime Mold and Myxomycetes Research
  • Evolutionary Game Theory and Cooperation
  • Plant Biochemistry and Biosynthesis

Gutterman has an active publication record with papers appearing in several notable scientific journals. Recent papers include:

  • "Avicin G is a potent sphingomyelinase inhibitor and blocks oncogenic K- and H-Ras signaling," 2020, published in Scientific Reports
  • "Can natural selection and druggable targets synergize? Of nutrient scarcity, cancer, and the evolution of cooperation," 2020, published in BioEssays
  • "Abstract 1033: The anticancer compound avicin D targets lysosomal functions," 2021, published in Cancer Research

Throughout their work, Gutterman has frequently collaborated with several researchers, including Christian M. Garrido, Karen M. Henkels, Kristen M. Rehl, Liang Hong, and Yong Zhou. These collaborations have contributed to their publications and research activities in the biomedical sciences.

Their research has appeared mainly in the following scientific venues:

  • Scientific Reports
  • BioEssays
  • Cancer Research

Best Publications

  • Synthesis of Messenger RNAs for Transforming Growth Factors α and β and the Epidermal Growth Factor Receptor by Human Tumors

    Rik Derynck;David V. Goeddel;Axel Ullrich;Jordan U. Gutterman

  • The Molecular Genetics of Philadelphia Chromosome–Positive Leukemias

    Razelle Kurzrock;Jordan U. Gutterman;Moshe Talpaz

  • Cytokine therapeutics: lessons from interferon alpha.

    Jordan U. Gutterman

  • The Energy Sensing LKB1-AMPK Pathway Regulates p27kip1 Phosphorylation Mediating the Decision to Enter Autophagy or Apoptosis

    Jiyong Liang;Shan H. Shao;Shan H. Shao;Zhi Xiang Xu;Bryan Hennessy

  • Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

    Jorge R. Quesada;James M Reuben;John T. Manning;Evan M. Hersh

  • Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaA in Chronic Myelogenous Leukemia

    Moshe Talpaz;Hagop M. Kantarjian;Kenneth McCredie;Jose M. Trujillo

  • Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.

    Saroj Vadhan-Raj;Michael Keating;Michael Keating;Anne Lemaistre;Anne Lemaistre;Walter N. Hittelman;Walter N. Hittelman

  • Clinical toxicity of interferons in cancer patients: a review.

    Jorge R. Quesada;Moshe Talpaz;Adan Rios;Razelle Kurzrock

  • Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

    Jordan U. Gutterman;George R. Blumenschein;Raymond Alexanian;Hwee-Yong Yap

  • Phase I Study of Recombinant Tumor Necrosis Factor in Cancer Patients

    Mark Blick;Stephen A. Sherwin;Michael Rosenblum;Jordan Gutterman

  • Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

    Jordan U. Gutterman;Seymour Fine;Jorge Quesada;Sandra J. Horning

  • 13-cis-Retinoic Acid and Interferon α -2a: Effective Combination. Therapy for Advanced Squamous Cell Carcinoma of the Skin

    Scott M. Lippman;David R. Parkinson;Loretta M. Itri;Randal S. Weber

  • Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous Leukemia: Philadelphia Chromosome-Positive Patients

    Moshe Talpaz;Hagop Kantarjian;Razelle Kurzrock;Jose M. Trujillo

  • Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia

    Moshe Talpaz;Kenneth B. McCredie;Giora M. Mavligit;Jordan U. Gutterman

  • Clinical investigation of human alpha interferon in chronic myelogenous leukemia.

    Moshe Talpaz;Hagop M. Kantarjian;Kenneth B. McCredie;Michael J. Keating

  • Renal cell carcinoma: antitumor effects of leukocyte interferon.

    Jorge R. Quesada;David A. Swanson;Antonio Trindade;Jordan U. Gutterman

  • Prognostic factors in metastatic breast cancer treated with combination chemotherapy.

    Kenneth D. Swenerton;Sewa S. Legha;Terry Smith;Gabriel N. Hortobagyi

  • A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia

    Razelle Kurzrock;Mordechai Shtalrid;Paolo Romero;William S. Kloetzer

  • Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.

    Jorge R. Quesada;Adan Rios;David Swanson;Patrick Trown

  • Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous Leukemia

    Moshe Talpaz;Hagop Kantarjian;Razelle Kurzrock;Jose M. Trujillo

Frequent Co-Authors

Evan M. Hersh
Evan M. Hersh The University of Texas MD Anderson Cancer Center
Razelle Kurzrock
Razelle Kurzrock Medical College of Wisconsin
Moshe Talpaz
Moshe Talpaz University of Michigan–Ann Arbor
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Gerald P. Bodey
Gerald P. Bodey The University of Texas MD Anderson Cancer Center
Emil J. Freireich
Emil J. Freireich The University of Texas MD Anderson Cancer Center
Gabriel N. Hortobagyi
Gabriel N. Hortobagyi The University of Texas MD Anderson Cancer Center
Michael J. Keating
Michael J. Keating The University of Texas MD Anderson Cancer Center
Terry L. Smith
Terry L. Smith The University of Texas MD Anderson Cancer Center
George R. Blumenschein
George R. Blumenschein The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up a variety of alternative and complementary pathways that can be pursued online. For those passionate about health and diet, there are online nutrition degree programs that prepare students for roles in wellness, public health, and medical nutrition therapy.

Students interested in healthcare leadership might consider cahme-accredited online mha programs. These programs equip graduates with advanced management and administrative skills needed for roles in hospitals, health systems, and nonprofit organizations.

For registered nurses looking to expand their credentials without the need for additional clinical requirements, rn to bsn programs no clinicals provide a flexible route to complete your bachelor’s degree and open doors to more advanced nursing positions.

Those seeking the highest levels of nursing qualification can consider short dnp programs that allow experienced nurses to earn a Doctor of Nursing Practice in less time and fully online.

Each of these online degree options fosters specialized skills and creates new career opportunities, making them excellent choices for students committed to making a difference in healthcare—whether at the bedside, in executive offices, or through health education.

Best Scientists Citing Jordan U. Gutterman

Trending Scientists

Recently Published Articles